Even though groups had related chance aspects and Original eye situations, the HBOT group, In spite of staying older with shorter symptom duration, confirmed noticeably enhanced final eyesight following adjusting for age, sex, and symptom duration. The study indicates incorporating HBOT to standard care enhances ultimate Visible results for CRAO, a